Effect of CCK-4 on a 35% carbon dioxide challenge in healthy volunteers

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 23, Issue 8, 1999, Pages 1345-1350

  Pols, Henk ^a   Griez, Eric ^a,c   Bourin, Michel ^b   Schruers, Koen ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITÉ DE NANTES   (France)

^c Academic Anxiety Center   (Netherlands)

Author keywords

Carbon dioxide; Cholecystokinin; Panic

Indexed keywords

CARBON DIOXIDE; TETRAGASTRIN;

ANXIETY; ARTICLE; CARBON DIOXIDE BREATHING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE TRACT; PANIC; RANDOMIZED CONTROLLED TRIAL;

ADULT; CARBON DIOXIDE; DOUBLE-BLIND METHOD; HUMANS; INHALATION EXPOSURE; PANIC DISORDER; TETRAGASTRIN;

EID: 0033230161     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(99)00070-6     Document Type: Article

References (8)

1. Bourin M, Malinge M, Vasar E and Bradwejn J (1996). Two faces of cholecystokinin: Anxiety and schizophrenia. Fundam Clin Pharmacol; 10: 116-126
2. 2 in panic disorder. Progr Neuropsychopharmacol & Biol Psychiat; 15: 237-239
3. Bradwejn J, Koszycki D. and Bourin M. (1991). Dose ranging study of the effects of cholecystokinin in healthy volunteers. J Psychiat & Neurosci; 16: 260-264
4. Bradwejn J., Legrand J.M, Koszycki D, Bates J and Bourin M (1998). Effects of cholecystokinintetrapeptide on respiratory function in healthy volunteers. Am J Psychiatry; 155: 280-282
5. Griez E. and Schruers K. (1998). Experimental pathophysiology of panic. J Psychosom Res; 45: 493-503
6. 2 and cholecystokinin-tetrapeptide in healthy volunteers. Eur Neuropsychopharmacol; 1: 137-141
7. Lecrubier Y, Sheehan D.V., Weiler E., Amorim P., Bonora I., Harnett Sheehan K., Janavs J. and Dunbar G.C. (1997). The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. Eur Psychiat; 12: 224-231
8. Van Megen H, Westenberg H, Den Boer J and Kahn R (1996). Cholecystokinin in anxiety. Eur Neuropsychopharmacol; 6: 263-280